APA (7th ed.) Citation

Laurence, V., Cordero, C., Dureau, S., Jehanno, N., Pierron, G., Gaspar, N., . . . Corradini, N. (2024). 1755P Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial. Annals of Oncology, 35, S1046. https://doi.org/10.1016/j.annonc.2024.08.1846

Chicago Style (17th ed.) Citation

Laurence, V., et al. "1755P Multimodal Therapy in First Line Treatment of Very High Risk Ewing Sarcoma Patients: Results of the French Prospective Multicenter COMBINAIR3 Phase II Trial." Annals of Oncology 35 (2024): S1046. https://doi.org/10.1016/j.annonc.2024.08.1846.

MLA (9th ed.) Citation

Laurence, V., et al. "1755P Multimodal Therapy in First Line Treatment of Very High Risk Ewing Sarcoma Patients: Results of the French Prospective Multicenter COMBINAIR3 Phase II Trial." Annals of Oncology, vol. 35, 2024, p. S1046, https://doi.org/10.1016/j.annonc.2024.08.1846.